PPARγ-IN-2
PPARγ-IN-2 (Compound 5a) is a PPARγ inhibitor. PPARγ-IN-2 inhibits TG accumulation in 3T3-L1 preadipocytes (EC50: 0.106 μM) . PPARγ-IN-2 inhibits high-cholesterol diet (HFC) -induced obesity and related metabolic syndrome, and reduces lipid accumulation in adipose tissue[1].
Product Specifications
CAS Number
2682078-97-1
UNSPSC
12352005
Target
PPAR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pparγ-in-2.html
Purity
99.57
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=CC1=C(C2=NC=CC(NCCN3CCCC3)=N2)NC4=CC=CC=C14
Molecular Formula
C19H21N5O
Molecular Weight
335.40
References & Citations
[1]Guo SY, et al. Design, synthesis and evaluation of 2-pyrimidinylindole derivatives as anti-obesity agents by regulating lipid metabolism. Eur J Med Chem. 2023 Nov 15;260:115729.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PPARγ
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
21326061 1.0 µg DNA
GAST Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
MBS1293686 Inquire
Recombinant Ralstonia metallidurans Alanine--tRNA ligase (alaS), partial
Sign In for Pricing
View Details